Corporate
Jan. 9, 2018
Emeryville drug developer tabs new general counsel
Biotech in-house veteran Danny Hart to lead legal team at XOMA Corp.
HART
Emeryville-based drug developer XOMA Corp. announced the appointment of Daniel J. Hart as general counsel Monday. A veteran in-house biotech attorney, Hart assumed his new role last month.
XOMA is coming off a period of significant growth. The company recorded total revenues of $36.2 million for the third quarter of 2017 thanks to license agreements with Swiss pharmaceutical giant Novartis AG inked last August. Since then, the compa...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In